Home » Newsletters » BioWorld Science

BioWorld Science

July 20, 2012

View Archived Issues

Novel FLAP inhibitors divulged by Boehringer Ingelheim

FKD Therapies clear to launch phase II Instiladrin study

Scientists in China links gene's expression levels to severity of cognitive impairment

Novel BACE inhibitor shows promise to treat Alzheimer's disease

Novel agents for hepatitis C prepared at Cocrystal Discovery

Spanish researchers patent new CB1 receptor ligands

Novel TLR7 agonists disclosed

Preclinical evaluation of OMS-824 complete

New antisense oligonucleotides designed at miRagen Therapeutics

Novel antivirals disclosed by Abbott

GSK vaccine candidate for shingles enters phase III study

MetaMax focuses on development of MM-D37K

Novel bile acid receptor agonists presented by IRM

Antinicotine gene therapy as a novel approach to nicotine addiction

Johnson & Johnson reviews highlights of second quarter 2012

NVP-BKM120 shows potential in models of follicular lymphoma

Milestone met in Amgen/Array BioPharma collaboration

Soricimed Biopharma to design biologic drug conjugates for oncology indications

FDA clears pivotal trials of sustained-release microinsert in uveitis

Phrixus Pharmaceuticals reports preclinical results for Carmeseal

Phase I trial commences of combination therapy for ovarian cancer

Phase I/II Actimab-A trial advances

Cytomedix collaborates with Duke University on brain cancer study

University of Alberta kicks off phase I/II study of pan-caspase inhibitor

NIH to test maraviroc-based drug regimens for HIV prevention

Sanofi and Regeneron launch phase III program for LDL-lowering antibody

Investigators at Bristol-Myers Squibb identify novel dAbs targeting CD40-L

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...